Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Diagnostic Value and Safety of Flecainide Infusion Test in Brugada Syndrome

NCT02302274 is registered in ClinicalTrials.gov with NYU Langone Health as lead sponsor.

NCT NCT02302274
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02302274 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Diagnostic Value and Safety of Flecainide Infusion Test in Brugada Syndrome
Lead sponsor
NYU Langone Health
Phase
Observational
Overall status
Completed
Start date
July 1, 2010
Completion date
July 26, 2017
Enrollment
209 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

arrhythmogenic right ventricular cardiomyopathy, brugada syndrome